Search Within

Neuroblastoma Service

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (20)
  3. Conference Paper (1)
Groups
  1. GSK Faculty (54)
  2. Human Oncology and Pathogenesis Program (54)
  3. Pediatrics, Department of (54)
  4. Tow Center for Developmental Oncology (TCDO) (50)
  5. Center for Hematologic Malignancies (47)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Nai-Kong Cheung (35)
  2. Marc Ladanyi (26)
  3. Shakeel Modak (21)
  4. Brian Kushner (16)
  5. Katharine Hsu (15)
  6. Neerav Shukla (14)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Pediatric Blood and Cancer (8)
  3. Clinical Cancer Research (6)
  4. Cancer Research (5)
  5. Blood (3)
  6. Medical and Pediatric Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Society of Clinical Oncology (10)
  3. Wiley Periodicals, Inc (8)
  4. Nature Publishing Group (5)
  5. American Society of Hematology (3)
  6. Cell Press (2)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Desmoplastic small round cell tumor 20 years after its discovery
    Journal Article

    Mora, J.; Modak, S.; Cheung, N. K.; Meyers, P.; de Alava, E.; Kushner, B.; Magnan, H.; Tirado, O. M.; Laquaglia, M.; Ladanyi, M.; more...
    Future Oncology (2015)

    Fulltext@MSK | Save
  • Predictors of overall survival in patients diagnosed with desmoplastic small round cell tumor (DSRCT)
    Meeting Abstract

    Shoushtari, A. N.; Qin, L. X.; Kuk, D.; Magnan, H. D.; Modak, S.; Wolden, S. L.; Cho, E. J.; Pallos, V.; Grubman, O.; Viny, A. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor
    Journal Article

    Cheung, I. Y.; Hsu, K.; Cheung, N. K. V.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Normally hyporesponsive unlicensed natural killer cells are stronglyactivated by neuroblastoma (Nb) in the presence of anti-gd2 monoclonal antibody (MoAb)
    Meeting Abstract

    Tarek, N.; Gallagher, M.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save